Elevated IGFBP3 levels in diabetic tears: A negative regulator of IGF-1 signaling in the corneal epithelium

Yu Chieh Wu, Benjamin R. Buckner, Meifang Zhu, Harrison D Cavanagh, Danielle M Robertson

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


To determine the ratio of IGFBP3:IGF-1 in normal and diabetic human tears, and in telomeraseimmortalized human corneal epithelial cells (hTCEpi) cultured under elevated glucose conditions and to correlate these changes with total and phosphorylated levels of IGF- 1R. Tear samples were collected noninvasively from diabetic subjects and non-diabetic controls; corneal sensitivity was assessed using a Cochet-Bonnet Aesthesiometer. Conditioned media were collected following culture of hTCEpi cells in normal (5 mM) and elevated (25 mM) glucose conditions; mannitol was used as an osmotic control. IGFBP3, IGF-1, and phosphorylated IGF-1R levels were assessed by ELISA. IGFBP3 and IGF-1R mRNA were assessed by real-time polymerase chain reaction (PCR). Total and phosphorylated IGF-1R expression in whole cell lysates was assessed by western blot. There was a 2.8-fold increase in IGFBP3 in diabetic tears compared to non-diabetic controls (P=0.006); IGF-1 levels were not significantly altered. No difference in corneal sensitivity was detected between groups. The concentration of IGFBP3 in tears was independent of IGF-1. Consistent with human tear measurements in vivo, IGFBP3 secretion was increased 2.2 fold (P<0.001) following culture of hTCEpi cells under elevated glucose conditions in vitro. Treatment with glucose and the mannitol control reduced IGFBP3 mRNA (P<0.001). Total IGF-1R levels were unchanged. The increase in the IGFBP3:IGF-1 ratio detected in diabetic tears compared to normal controls blocked phosphorylation of the IGF-1R by IGF-1 (P<0.001) when tested in vitro. Taken together, these in vivo and confirmatory in vitro findings suggest that the observed increase in IGFBP3 found in human tears may attenuate IGF- 1R signaling in the diabetic cornea. A long-term increase in IGFBP3 may contribute to epithelial compromise and the pathogenesis of ocular surface complications reported in diabetes.

Original languageEnglish (US)
Pages (from-to)100-107
Number of pages8
JournalOcular Surface
Issue number2
StatePublished - Apr 2012


  • Cornea
  • Diabetes
  • Epithelium
  • IGF-1
  • IGF-1R
  • IGFBP3
  • Tears

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Elevated IGFBP3 levels in diabetic tears: A negative regulator of IGF-1 signaling in the corneal epithelium'. Together they form a unique fingerprint.

Cite this